Skip to main content
. 2022 Sep 14;187(5):719–731. doi: 10.1530/EJE-22-0454

Figure 2.

Figure 2

(A) ICARO score distribution in controls (blue), patients with Cushing’s syndrome (CS) (red lines), and patients with mild autonomous cortisol secretion (MACS) (orange dots). (B) ICARO score distribution in controls (blue), patients with primary adrenal insufficiency (PAI) (green lines), and patients with secondary adrenal insufficiency (SAI) (pink squares).